Sophia Genetics SA at Barclays Global Healthcare Conference Transcript
Good morning, everybody. My name is Luke Sergott. I cover life science tools and diagnostics here at Barclays. It's my pleasure to introduce Jurgi Camblong, SOPHiA GENETICS.
Questions & Answers
So -- let's kind of walk through here. You guys printed last night. Let's just walk through the puts and takes of the quarter and really how the year shook out versus your expectations then we can start digging into the guidance and then the business.
Sure. And thank you for the invite and good morning all. So indeed, yesterday, we reiterated our guidance, right, that we shared beginning of the year for 2022. And to give you some context, I think we're chatting about that. The business we have at SOPHiA makes that our visibility and forward-looking performance, it's quite good, right? Given we
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
